TREPPO, Elena
 Distribuzione geografica
Continente #
AS - Asia 790
NA - Nord America 624
EU - Europa 314
SA - Sud America 154
AF - Africa 21
OC - Oceania 4
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.909
Nazione #
US - Stati Uniti d'America 600
SG - Singapore 402
BR - Brasile 130
CN - Cina 127
HK - Hong Kong 89
IT - Italia 88
VN - Vietnam 81
RU - Federazione Russa 55
DE - Germania 34
KR - Corea 23
GB - Regno Unito 18
IN - India 17
FR - Francia 16
IE - Irlanda 14
AR - Argentina 13
AT - Austria 13
PL - Polonia 13
CA - Canada 12
FI - Finlandia 12
NL - Olanda 11
SE - Svezia 10
ZA - Sudafrica 10
PK - Pakistan 7
ES - Italia 6
IQ - Iraq 6
MX - Messico 6
BD - Bangladesh 5
ID - Indonesia 5
JP - Giappone 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
TG - Togo 4
BE - Belgio 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
TR - Turchia 3
UA - Ucraina 3
UZ - Uzbekistan 3
CH - Svizzera 2
EC - Ecuador 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PT - Portogallo 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.909
Città #
Singapore 184
Ashburn 147
Hong Kong 83
Beijing 66
Boardman 31
Los Angeles 31
Chandler 29
Hefei 25
Seoul 23
Dallas 21
Hanoi 17
Ho Chi Minh City 17
Redondo Beach 17
Dublin 14
Buffalo 13
New York 13
Warsaw 13
Dong Ket 12
Ann Arbor 11
Belluno 11
Nuremberg 11
Frankfurt am Main 10
Milan 10
São Paulo 10
Düsseldorf 9
Wilmington 9
Woodbridge 9
Denver 8
Houston 8
Lappeenranta 8
Princeton 8
Santa Clara 8
Stockholm 8
Udine 8
Fairfield 7
London 7
Mumbai 7
Seattle 7
Amsterdam 6
Brooklyn 6
Cambridge 6
Johannesburg 6
Ogden 6
Biên Hòa 5
Florence 5
Lauterbourg 5
Taranto 5
Toronto 5
Vienna 5
Atlanta 4
Chennai 4
Helsinki 4
Jakarta 4
Lomé 4
Phoenix 4
Rimini 4
Tokyo 4
Trieste 4
Xi'an 4
Athens 3
Boston 3
Brussels 3
Campinas 3
Christchurch 3
Colombo 3
Crema 3
Guarulhos 3
Lahore 3
Lucca 3
Newark 3
North Bergen 3
Querétaro 3
Rio de Janeiro 3
Rosario 3
Tashkent 3
Vũng Tàu 3
Albufeira 2
Amman 2
Ankara 2
Basra 2
Belo Horizonte 2
Bergamo 2
Bắc Giang 2
Calgary 2
Can Tho 2
Chicago 2
Codroipo 2
Council Bluffs 2
Des Moines 2
Duque de Caxias 2
Guangzhou 2
Hyderabad 2
Hải Dương 2
Jacksonville 2
La Paz 2
Marília 2
Mauá 2
Mazzano 2
Montevideo 2
Montreal 2
Totale 1.129
Nome #
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) 94
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 92
Rituximab induction and maintenance in ANCA-associated vasculitis: State of the art and future perspectives 87
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 81
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 80
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 77
Sjögren's disease and systemic lupus erythematosus overlap syndrome as distinct entity at the crossroads of two autoimmune disorders: clinical characterisation from two Italian reference centres for both diseases 75
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases 75
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis 71
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 71
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak 65
Systemic vasculitis: one year in review 2024 65
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis 63
The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sjögren's disease: a monocentric cohort study 62
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 62
Systemic vasculitis: one year in review 2022 62
Systemic vasculitis: one year in review 2023 61
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 58
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres 58
Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome 57
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 57
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis 55
Paraproteinemias Associated with Autoimmune Diseases 55
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 55
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 54
Rheumatologic manifestations of Hepatitis C Virus 50
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years 46
One year in review 2020: vasculitis 44
Mass-Forming Variants in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diagnostic Complexities in Granulomatous Disease. A Case Report 44
One year in review 2021: systemic vasculitis 44
The paradigm shift in ANCA-Associated vasculitis: Prime time for the complement targeting 41
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets 37
Systemic vasculitis: one year in review 2025 29
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study 17
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature 5
Totale 2.049
Categoria #
all - tutte 10.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 4 3 8 8 4 4 13
2021/202258 4 2 6 4 0 0 9 6 0 10 7 10
2022/202394 10 4 11 5 10 15 0 5 15 11 4 4
2023/202498 15 10 9 3 13 3 1 4 9 11 8 12
2024/2025839 14 73 44 28 35 31 83 69 118 61 143 140
2025/2026880 150 165 129 114 247 75 0 0 0 0 0 0
Totale 2.049